echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The JIU team has made a major breakthrough in the field of obesity and metabolic diseases

    The JIU team has made a major breakthrough in the field of obesity and metabolic diseases

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    China News Service, Guangzhou, November 25 (Reporter Guo Jun) The Institute of Biomedical Translational Research of Jinan University Medical Department held a press conference in Guangzhou on the 25th to announce that the team of Professor Yin Zhinan of the hospital has worked hard for 7 years in the field of obesity and metabolic diseases.


    Related research papers were published online on November 24 in the top international academic journal Nature


    According to reports, adipocytes are divided into white fat, brown fat and beige fat according to their morphology, metabolism, location and development


    Professor Yin Zhinan’s team built a high-fat diet-induced obesity model in mice, and combined with samples of obese people, they found that the level of IL-27 in the serum of obese people decreased, and for the first time found that IL-27 can directly act on non-immune cells--fat Cells, causing white adipocytes to brown, and activate the key protein of thermogenesis-uncoupling protein UCP1 mediated "fat burning"; by converting the lipids in adipose tissue into calories for consumption, so as to reduce weight and improve The purpose of metabolic diseases such as diabetes


    According to reports, this is also the first time researchers have discovered that IL-27 in the IL-12 cytokine family can directly act on adipocytes and cause adipocyte differentiation and thermogenesis, providing a new target for the treatment of obesity and metabolic diseases


    In recent years, obesity-induced metabolic syndromes such as type 2 diabetes, non-alcoholic fatty liver, and atherosclerosis have become major public health challenges


    This research is strongly supported by the key research and development program of the Ministry of Science and Technology of China, the key project of the National Natural Science Foundation of China, the discipline innovation and intelligence introduction base of the Ministry of Education, and the high-level hospital discipline construction funding of Zhuhai People's Hospital


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.